MDGL
Madrigal Pharmaceuticals, Inc.Healthcare$546.89
▲ Bullish
Mkt Cap: $12.55B|Float: 12.5M|SI: 31.5%|DTC: 10.6
Data as of market close Apr 2, 2026
IV Rank
46
IV Pctl
78%
HV 20d
49.3%
52W Range
$265-$615
ATR(14)
$27.88
Exp. Move
±4.1%
P/C Ratio
0.40
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
MDGL Key Options Data
- IV Rank
- 46.4%
- Total GEX
- $0.00B
- Total DEX
- $0.7M
- Max Pain
- $440.00
- Expected Move
- ±4.1%
- Put/Call OI
- 0.40
- Net Premium
- $13.8M
- Spot Price
- $546.89
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$22.50 | ±4.1% | $524.39 | $569.39 |
| 2026-05-15 | 43 | ±$41.65 | ±7.6% | $505.24 | $588.54 |
| 2026-07-17 | 106 | ±$61.95 | ±11.3% | $484.94 | $608.84 |
| 2026-10-16 | 197 | ±$83.10 | ±15.2% | $463.79 | $629.99 |
| 2026-12-18 | 260 | ±$257.55 | ±47.1% | $289.34 | $804.44 |
| 2027-01-15 | 288 | ±$100.95 | ±18.5% | $445.94 | $647.84 |
Explore MDGL options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.